Cargando…
Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports
BACKGROUND: Renal cell carcinoma represents 3–5% of adult malignant tumors. Metastases are found in 30–40% of patients and brain metastases occurred in more than 10% of them. Despite significant progress in medical treatment, patients with brain metastases still have a limited survival. Cabozantinib...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260776/ https://www.ncbi.nlm.nih.gov/pubmed/30474572 http://dx.doi.org/10.1186/s13256-018-1875-9 |